Can GLP-1 cause thyroid cancer?

The boxed warning is based on rodent studies showing medullary thyroid carcinoma (MTC) in mice and rats. No human cases have been attributed to GLP-1 use despite 10+ years post-approval surveillance.

Do GLP-1 medications affect mood or depression?

Mixed evidence. The FDA label has a precaution but no boxed warning. Some patients report improved mood (likely from weight loss + glycemic control); a smaller subset reports increased anxiety or low mood, especially in early weeks. Pre-existing depression history is a flag for closer monitoring.

How do you store GLP-1 pens?

Refrigerate unopened pens at 36-46°F (2-8°C) until first use. Once started, room temperature ≤86°F (30°C) is fine for up to 28 days. Never freeze; never store in direct sunlight; do not store in checked luggage.

How do you inject a GLP-1 safely?

Rotate sites between abdomen (≥2 inches from navel), front of thigh, and back of upper arm. Inject at room temperature (cold pens sting). Pinch a fold of skin, insert at 90°, hold 6 seconds after the click, withdraw straight. Dispose in a sharps container.

How does Wegovy compare to Saxenda?

Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Medication comparison

Saxenda vs Zepbound

Saxenda and Zepbound are both prescription medications (GLP-1 receptor agonist (daily injection) vs GIP/GLP-1 dual receptor agonist) used for Chronic weight management (adults + adolescents 12+) and Chronic weight management. The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Drug A

Saxenda

liraglutide

GLP-1 receptor agonist (daily injection)

Novo Nordisk

See full overview

Drug B

Zepbound

tirzepatide

GIP/GLP-1 dual receptor agonist

Eli Lilly

See full overview

Property	Saxenda	Zepbound
Generic name	liraglutide	tirzepatide
Drug class	GLP-1 receptor agonist (daily injection)	GIP/GLP-1 dual receptor agonist
Manufacturer	Novo Nordisk	Eli Lilly
Approved indications	Chronic weight management (adults + adolescents 12+)	Chronic weight management, Obstructive sleep apnea (adults with obesity)
Brand names	Saxenda	Zepbound
Typical dosing	—	Titrate to 15 mg (weekly SC injection)
Top side effects	—	Nausea (29.6%), Diarrhea (23%), Vomiting (12.6%)
Contraindications	—	—
Boxed warning	No	Yes
Pregnancy	—	C — Discontinue at least 1 month before a planned pregnancy.
Storage	—	Refrigerate before first use. After first use, room temperature up to 21 days.
Avg monthly cost	$1349.00	$1059.87

FDA boxed warning

Zepbound: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Frequently asked

What is the difference between Saxenda and Zepbound?

Saxenda is liraglutide (GLP-1 receptor agonist (daily injection)) and Zepbound is tirzepatide (GIP/GLP-1 dual receptor agonist). They have different active ingredients and slightly different side-effect profiles.

Is Saxenda or Zepbound more effective for weight loss?

Head-to-head trial data favors tirzepatide-based medications (Mounjaro, Zepbound) over semaglutide-based medications (Ozempic, Wegovy) in average percent weight loss. See each drug's clinical-trials section for SURMOUNT and STEP trial data.

Can I switch between Saxenda and Zepbound?

Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.

More medication context

Tools and guides that pair with this comparison.

Common questions readers ask

Can GLP-1 cause thyroid cancer?: The boxed warning is based on rodent studies showing medullary thyroid carcinoma (MTC) in mice and rats. No human cases have been attributed to GLP-1 use despite 10+ years post-approval surveillance.
Do GLP-1 medications affect mood or depression?: Mixed evidence. The FDA label has a precaution but no boxed warning. Some patients report improved mood (likely from weight loss + glycemic control); a smaller subset reports increased anxiety or low mood, especially in early weeks. Pre-existing depression history is a flag for closer monitoring.
How do you store GLP-1 pens?: Refrigerate unopened pens at 36-46°F (2-8°C) until first use. Once started, room temperature ≤86°F (30°C) is fine for up to 28 days. Never freeze; never store in direct sunlight; do not store in checked luggage.
How do you inject a GLP-1 safely?: Rotate sites between abdomen (≥2 inches from navel), front of thigh, and back of upper arm. Inject at room temperature (cold pens sting). Pinch a fold of skin, insert at 90°, hold 6 seconds after the click, withdraw straight. Dispose in a sharps container.
How does Wegovy compare to Saxenda?: Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.

Saxenda vs Zepbound

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Property	Saxenda	Zepbound
Generic name	liraglutide	tirzepatide
Drug class	GLP-1 receptor agonist (daily injection)	GIP/GLP-1 dual receptor agonist
Manufacturer	Novo Nordisk	Eli Lilly
Approved indications	Chronic weight management (adults + adolescents 12+)	Chronic weight management, Obstructive sleep apnea (adults with obesity)
Brand names	Saxenda	Zepbound
Typical dosing	—	Titrate to 15 mg (weekly SC injection)
Top side effects	—	Nausea (29.6%), Diarrhea (23%), Vomiting (12.6%)
Contraindications	—	—
Boxed warning	No	Yes
Pregnancy	—	C — Discontinue at least 1 month before a planned pregnancy.
Storage	—	Refrigerate before first use. After first use, room temperature up to 21 days.
Avg monthly cost	$1349.00	$1059.87

FDA boxed warning

Zepbound: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Frequently asked

What is the difference between Saxenda and Zepbound?

Is Saxenda or Zepbound more effective for weight loss?

Can I switch between Saxenda and Zepbound?

Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.

Common questions readers ask

Can GLP-1 cause thyroid cancer?: The boxed warning is based on rodent studies showing medullary thyroid carcinoma (MTC) in mice and rats. No human cases have been attributed to GLP-1 use despite 10+ years post-approval surveillance.
Do GLP-1 medications affect mood or depression?: Mixed evidence. The FDA label has a precaution but no boxed warning. Some patients report improved mood (likely from weight loss + glycemic control); a smaller subset reports increased anxiety or low mood, especially in early weeks. Pre-existing depression history is a flag for closer monitoring.
How do you store GLP-1 pens?: Refrigerate unopened pens at 36-46°F (2-8°C) until first use. Once started, room temperature ≤86°F (30°C) is fine for up to 28 days. Never freeze; never store in direct sunlight; do not store in checked luggage.
How do you inject a GLP-1 safely?: Rotate sites between abdomen (≥2 inches from navel), front of thigh, and back of upper arm. Inject at room temperature (cold pens sting). Pinch a fold of skin, insert at 90°, hold 6 seconds after the click, withdraw straight. Dispose in a sharps container.
How does Wegovy compare to Saxenda?: Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.

Saxenda vs Zepbound

Saxenda

Zepbound

Frequently asked

More medication context

Saxenda full overview

Zepbound full overview

GLP-1 shortage tracker

Are you a candidate?

Prior auth letter generator

12-month price trends

Common questions readers ask

Saxenda vs Zepbound

Saxenda

Zepbound

Frequently asked

More medication context

Saxenda full overview

Zepbound full overview

GLP-1 shortage tracker

Are you a candidate?

Prior auth letter generator

12-month price trends

Common questions readers ask